de Faria, Tatiany J <br/><br/>
An isoniazid analogue promotes Mycobacterium tuberculosis-nanoparticle interactions and enhances bacterial killing by macrophages.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  May 2012 
 - 2259-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.05993-11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antitubercular Agents--pharmacology<br/>Biological Availability<br/>Cells, Cultured<br/>Drug Compounding<br/>Drug Delivery Systems--methods<br/>Hydrogen-Ion Concentration<br/>Hydrophobic and Hydrophilic Interactions<br/>Isoniazid--analogs & derivatives<br/>Lactic Acid--chemistry<br/>Macrophages--drug effects<br/>Mice<br/>Microscopy, Atomic Force<br/>Microscopy, Confocal<br/>Mycobacterium tuberculosis--drug effects<br/>Nanoparticles<br/>Particle Size<br/>Phagocytosis<br/>Polyglycolic Acid--chemistry<br/>Polylactic Acid-Polyglycolic Acid Copolymer<br/>Tuberculosis, Pulmonary--drug therapy